 Nine Poster Presentations Include New Analyses of SILIQ and JUBLIA LAVAL, QC ACCESSWIRE November 1, 2022 - Bausch Health Companies Inc. NYSE:BHCTSX:BHC Bausch Health and its dermatology business, Ortho Dermatologics, today announced the presentation of nine posters during the Innovations in Dermatology Conference, which takes place Nov. 3-5, 2022, in Las Vegas, Nev. The presentations will feature new data around JUBLIA efinaconazole Topical Solution, 10, and SILIQ brodalumab Injection, 210 mg1.5 mL. 